Does EVOLOCUMAB Cause Laboratory test abnormal? 265 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 265 reports of Laboratory test abnormal have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.2% of all adverse event reports for EVOLOCUMAB.
265
Reports of Laboratory test abnormal with EVOLOCUMAB
0.2%
of all EVOLOCUMAB reports
0
Deaths
23
Hospitalizations
How Dangerous Is Laboratory test abnormal From EVOLOCUMAB?
Of the 265 reports, 23 (8.7%) required hospitalization, and 2 (0.8%) were considered life-threatening.
Is Laboratory test abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 265 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Laboratory test abnormal?
LENALIDOMIDE (4,215)
CINACALCET (4,210)
POMALIDOMIDE (1,218)
ADALIMUMAB (845)
ETANERCEPT (753)
DALFAMPRIDINE (650)
PALBOCICLIB (550)
NIRAPARIB (536)
METHOTREXATE (507)
ECULIZUMAB (441)
Which EVOLOCUMAB Alternatives Have Lower Laboratory test abnormal Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE